Change is on the horizon for cath labs all over the world as more and more interventional cardiologists are starting to use coronary CT angiography to plan and guide PCI procedures. Patients, physicians, catheterization labs and healthcare systems all stand to gain from this growing trend.

Identifying patients with severe aortic stenosis who could potentially benefit from transcatheter aortic valve replacement (TAVR) is very important—but managing and tracking them over time can be quite a challenge.

When the ACC and AHA collaborated on new valvular heart disease guidelines in 2020, the two groups highlighted the importance of interventional treatment options such as TAVR. However, an estimated one-third of patients with severe aortic stenosis in the U.S. still lack a guideline-recommended treatment plan.

Aortic stenosis (AS) is one of the most common—and growing—cardiac conditions. In particular, the prevalence of severe AS rises markedly among elderly Americans, affecting an estimated 3.4% of Americans 75 and older.[1]

Updates about transcatheter aortic valve replacement (TAVR) are always big news, but the new five-year data from the CoreValve™ US Pivotal and SURTAVI trials came as a welcome surprise to many cardiologists. 

The trend to get PCI patients out of the hospital safely on the same day as their procedure has long been a goal for many health systems. WellStar Kennestone Regional Hospital, part of WellStar Health System in Atlanta, made same-day discharge for a vast majority of PCI patients a mission three years ago.

Thinking has changed: Cardiac implantable electronic device (CIED) infections are a bigger deal than we thought.

AirECMO, Inc., a division of Keystone Perfusion Services, P.C. announces a strategic partnership with industry leading air ambulance provider, REVA, to provide ECMO transportation capabilities globally. ECMO is an extracorporeal technique of providing prolonged cardiac and respiratory support to persons whose heart and lungs are unable to maintain hemodynamic stability.